Patents by Inventor Robert M. Nakamura

Robert M. Nakamura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7056062
    Abstract: A method for using large chambers, located deep within the earth, for the disposal of processed waste is disclosed. In this context, waste includes solid waste from sewage, and other organic-waste materials from urban, agricultural or industrial sources. These wastes will be processed by mechanical pulverization and hydration to produce a slurry, which will be injected into the well's chamber. The anaerobic condition in the chamber will be conducive to the production of gases, especially methane which will be harvested as a source of industrial fuel. Hydrogen, ammonia and other gases will also be harvested. This system will alleviate the acute problem of disposal of wastes from urban agricultural and industrial sources. It will decrease pollution of the air with greenhouse gases and pollution of the land area water with organic wastes and also release of disease-causing pathogens. The system may be adapted to facilitate the disposal of nuclear wastes.
    Type: Grant
    Filed: July 14, 2003
    Date of Patent: June 6, 2006
    Inventors: Richard T. Takeuchi, Robert M. Nakamura
  • Patent number: 6162787
    Abstract: The invention describes compositions and methods for treatment of rheumatoid arthritis and osteoarthritis. The compositions comprise insoluble, native collagen Type II in a particular form in combinations with other active agents, including glucosamine, chondroitin, ascorbate, boron and magnesium. Also described are methods for producing particulated insoluble native collagen Type II.
    Type: Grant
    Filed: April 2, 1999
    Date of Patent: December 19, 2000
    Assignee: Immudyne, Inc.
    Inventors: Nino Sorgente, Robert M. Nakamura
  • Patent number: 4477577
    Abstract: A method for direct serum assay of steroid hormones wherein the competition from binding protein, having an affinity for complexing with the steroid hormones, is significantly eliminated by adding to the serum an artificial compound which has a greater or equal affinity for the binding protein than do the steroid hormones, and which is not immuno-reactive with the steroid hormones. Because the compound is artificial, it is non-contaminating. Levonorgestrel and norethindrone as such compounds are disclosed.
    Type: Grant
    Filed: September 18, 1981
    Date of Patent: October 16, 1984
    Assignee: University of Southern California
    Inventors: Robert M. Nakamura, Daniel R. Mishell, Paul G. Stumpf
  • Patent number: 4320109
    Abstract: An immunoradiometric assay in which an antigen is reacted to its specific antibody, which complex is then separated and further reacted with a second, universal antibody. This second, universal antibody contains a chelating moiety, such as transferrin, capable of binding specifically and strongly short-lived radionuclides. The second complex, once formed is reacted with a radionuclide and the radio-activity is measured, determining thereby the quantity of the unknown antigen originally present.
    Type: Grant
    Filed: June 29, 1979
    Date of Patent: March 16, 1982
    Assignee: The University of Southern California
    Inventors: Walter Wolf, Robert M. Nakamura, Ata Gokce, Manuel Tubis, Timothy J. O'Brien
  • Patent number: 4004582
    Abstract: An intracervical contraceptive device (ICD) is provided with an elongated, circular cylindrical stem having a hollow bore which allows the flow of fluids from the uterus. Two opposed long arms and two opposed short arms are formed at one end of the stem and extend into the uterine cavity to prevent inadvertent expulsion of the device. The long arms flair outwardly in the lateral plane of the uterine cavity while the short arms flair outwardly in a plane parallel to the anterior-posterior plane of the uterine cavity. A barrel-shaped sleeve surrounds the stem and initially conforms to the contour of the walls of the cervical canal. The sleeve is composed of a biodegradable binder material impregnated with a pharmaceutical agent which prevents spermatozoa from performing their fertilization function when the pharmaceutical agent is released into fluids passing over the sleeve.
    Type: Grant
    Filed: October 28, 1975
    Date of Patent: January 25, 1977
    Inventors: Robert M. Nakamura, Val Davajan